to the European Medicines Agency (EMA) for trofinetide for the treatment of Rett syndrome in adults and pediatric patients two years of age and older. If granted marketing authorization ...
Despite the negative notification from the Commission, the Bulgarian government, which is working ... Agency (EMA) in the event of a critical shortage of medicines in order to use the European ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback